• Something wrong with this record ?

Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry

M. Arrigo, E. Gayat, J. Parenica, S. Ishihara, J. Zhang, DJ. Choi, JJ. Park, KF. Alhabib, N. Sato, O. Miro, AP. Maggioni, Y. Zhang, J. Spinar, A. Cohen-Solal, TJ. Iwashyna, A. Mebazaa, . ,

. 2017 ; 19 (2) : 201-208. [pub] 20161028

Language English Country Great Britain

Document type Journal Article, Observational Study

Persistent link   https://www.medvik.cz/link/bmc18016953

AIMS: Several clinical conditions may precipitate acute heart failure (AHF) and influence clinical outcome. In this study we hypothesized that precipitating factors are independently associated with 90-day risk of death in AHF. METHODS AND RESULTS: The study population consisted of 15 828 AHF patients from Europe and Asia. The primary outcome was 90-day all-cause mortality according to identified precipitating factors of AHF [acute coronary syndrome (ACS), infection, atrial fibrillation (AF), hypertension, and non-compliance]. Mortality at 90 days was 15.8%. AHF precipitated by ACS or by infection showed increased 90-day risk of death compared with AHF without identified precipitants [hazard ratio (HR) 1.69, 95% confidence interval (CI) 1.44-1.97, P < 0.001; and HR 1.51, 95% CI 1.18-1.92, P = 0.001), while AHF precipitated by AF showed lower 90-day risk of death (HR 0.56, 95% CI 0.42-0.75, P < 0.001), after multivariable adjustment. The risk of death in AHF precipitated by ACS was the highest during the first week after admission, while in AHF precipitated by infection the risk of death had a delayed peak at week 3. In AHF precipitated by AF, a trend toward reduced risk of death during the first weeks was shown. At weeks 5-6, AHF precipitated by ACS, infection, or AF showed similar risk of death to that of AHF without identified precipitants. CONCLUSIONS: Precipitating factors are independently associated with 90-day mortality in AHF. AHF precipitated by ACS or infection is independently associated with higher, while AHF precipitated by AF is associated with lower 90-day risk of death.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016953
003      
CZ-PrNML
005      
20180523095641.0
007      
ta
008      
180515s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ejhf.682 $2 doi
035    __
$a (PubMed)27790819
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Arrigo, Mattia $u INSERM UMR-S 942, Université Paris Diderot, PRES Sorbonne Paris Cité, and Department of Anaesthesiology and Critical Care Medicine, APHP-Saint Louis Lariboisière University Hospitals, Paris, France. Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
245    10
$a Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry / $c M. Arrigo, E. Gayat, J. Parenica, S. Ishihara, J. Zhang, DJ. Choi, JJ. Park, KF. Alhabib, N. Sato, O. Miro, AP. Maggioni, Y. Zhang, J. Spinar, A. Cohen-Solal, TJ. Iwashyna, A. Mebazaa, . ,
520    9_
$a AIMS: Several clinical conditions may precipitate acute heart failure (AHF) and influence clinical outcome. In this study we hypothesized that precipitating factors are independently associated with 90-day risk of death in AHF. METHODS AND RESULTS: The study population consisted of 15 828 AHF patients from Europe and Asia. The primary outcome was 90-day all-cause mortality according to identified precipitating factors of AHF [acute coronary syndrome (ACS), infection, atrial fibrillation (AF), hypertension, and non-compliance]. Mortality at 90 days was 15.8%. AHF precipitated by ACS or by infection showed increased 90-day risk of death compared with AHF without identified precipitants [hazard ratio (HR) 1.69, 95% confidence interval (CI) 1.44-1.97, P < 0.001; and HR 1.51, 95% CI 1.18-1.92, P = 0.001), while AHF precipitated by AF showed lower 90-day risk of death (HR 0.56, 95% CI 0.42-0.75, P < 0.001), after multivariable adjustment. The risk of death in AHF precipitated by ACS was the highest during the first week after admission, while in AHF precipitated by infection the risk of death had a delayed peak at week 3. In AHF precipitated by AF, a trend toward reduced risk of death during the first weeks was shown. At weeks 5-6, AHF precipitated by ACS, infection, or AF showed similar risk of death to that of AHF without identified precipitants. CONCLUSIONS: Precipitating factors are independently associated with 90-day mortality in AHF. AHF precipitated by ACS or infection is independently associated with higher, while AHF precipitated by AF is associated with lower 90-day risk of death.
650    _2
$a akutní koronární syndrom $x epidemiologie $7 D054058
650    _2
$a akutní nemoc $7 D000208
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a Asie $x epidemiologie $7 D001208
650    _2
$a fibrilace síní $x epidemiologie $7 D001281
650    _2
$a příčina smrti $7 D002423
650    _2
$a Evropa $x epidemiologie $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční selhání $x epidemiologie $x mortalita $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x epidemiologie $7 D006973
650    _2
$a infekce $x epidemiologie $7 D007239
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a mortalita $7 D009026
650    _2
$a adherence pacienta $x statistika a číselné údaje $7 D010349
650    _2
$a precipitační faktory $7 D015985
650    _2
$a prognóza $7 D011379
650    _2
$a proporcionální rizikové modely $7 D016016
650    _2
$a prospektivní studie $7 D011446
650    12
$a registrace $7 D012042
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Gayat, Etienne $u INSERM UMR-S 942, Université Paris Diderot, PRES Sorbonne Paris Cité, and Department of Anaesthesiology and Critical Care Medicine, APHP-Saint Louis Lariboisière University Hospitals, Paris, France.
700    1_
$a Parenica, Jiri $u Department of Cardiology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
700    1_
$a Ishihara, Shiro $u Division of Cardiology and Intensive Care Unit, Nippon Medical School Musashi-Kosugi Hospital, Kawasaki, Japan.
700    1_
$a Zhang, Jian $u Heart Failure Center Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
700    1_
$a Choi, Dong-Ju $u Division Cardiology, Cardiovascular Center, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, South Korea.
700    1_
$a Park, Jin Joo $u Division Cardiology, Cardiovascular Center, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, South Korea.
700    1_
$a Alhabib, Khalid F $u Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
700    1_
$a Sato, Naoki $u Division of Cardiology and Intensive Care Unit, Nippon Medical School Musashi-Kosugi Hospital, Kawasaki, Japan.
700    1_
$a Miro, Oscar $u Emergency Department, Hospital Clínic and 'Emergencies: Processes and Pathologies' Research Group, IDIBAPS, Barcelona, Spain.
700    1_
$a Maggioni, Aldo P $u ANMCO Research Center, Florence, Italy.
700    1_
$a Zhang, Yuhui $u Heart Failure Center Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
700    1_
$a Spinar, Jindrich $u Department of Cardiology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
700    1_
$a Cohen-Solal, Alain $u INSERM UMR-S 942, Université Paris Diderot, PRES Sorbonne Paris Cité, and Department of Cardiology, APHP-Lariboisière University Hospital, Paris, France.
700    1_
$a Iwashyna, Theodore J $u Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
700    1_
$a Mebazaa, Alexandre $u INSERM UMR-S 942, Université Paris Diderot, PRES Sorbonne Paris Cité, and Department of Anaesthesiology and Critical Care Medicine, APHP-Saint Louis Lariboisière University Hospitals, Paris, France.
700    1_
$a ,
773    0_
$w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 19, č. 2 (2017), s. 201-208
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27790819 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180523095826 $b ABA008
999    __
$a ok $b bmc $g 1300577 $s 1013793
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 19 $c 2 $d 201-208 $e 20161028 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Archiving options